Fwd: FDA Issues Emergency Use Authorization For Monoclonal Antibody Combination For Patients With Mild To Moderate SARS-CoV-2 At Risk For Severe COVID-19 Gertie Chimeka Anyanwoke 11 Feb 2021 09:26 CST